Related Experiment Videos
Immune hydrops fetalis attributable to anti-HJK
D Rouse1, C Weiner, R Williamson
1Department of Obstetrics and Gynecology, University of Iowa College of Medicine, Iowa City.
Obstetrics and Gynecology
|November 1, 1990
Summary
A novel low-frequency antigen, HJK, caused immune hydrops fetalis in a fetus. Successful treatment was achieved through intravascular transfusion, highlighting a new diagnostic and therapeutic target.
Area of Science:
- Immunology
- Perinatology
- Genetics
Background:
- Immune hydrops fetalis (IHF) poses significant risks to fetal well-being.
- Accurate identification of causative antigens is crucial for diagnosis and management.
- Low-frequency antigens present diagnostic challenges in blood group serology.
Observation:
- A fetus at 27 weeks gestation presented with severe anemia (hematocrit 6%) and hydrops fetalis.
- Serological investigation revealed a potential new low-frequency antigen, temporarily designated HJK.
- The fetal condition was attributed to an immune response against this novel antigen.
Findings:
- The HJK antigen was identified as the causative agent of immune hydrops fetalis in this case.
- The affected fetus responded successfully to intravascular transfusion.
- The HJK antigen appears to be a rare, likely familial, blood group determinant.
Implications:
- This discovery expands the known spectrum of red blood cell antigens implicated in hemolytic disease of the fetus and newborn.
- The identification of HJK necessitates further research into its prevalence and clinical significance.
- Improved diagnostic and management strategies for IHF may arise from understanding rare antigen incompatibilities.